Global Hereceptin Biosimilar Market Insights and Forecast to 2026
- BMR3911193
- 111 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Hereceptin Biosimilar was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Hereceptin Biosimilar is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Hereceptin Biosimilar market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hereceptin Biosimilar market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Hereceptin Biosimilar industry.
Global Hereceptin Biosimilar Scope and Segment
Hereceptin Biosimilar market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereceptin Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Mylan N.V.
AryoGen Biopharma
Genor Biopharma
Celltrion Inc.
Amgen Inc.
Mabion S.A.
The Instituto Vital Brazil
F. Hoffmann-La Roche AG
Biocon
Gedeon Richter Plc
Hereceptin Biosimilar Breakdown Data by Type
Tablet
Capsule
Hereceptin Biosimilar Breakdown Data by Application
Pharmaceuticals
Healthcare
Others
Regional and Country-level Analysis
The Hereceptin Biosimilar market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hereceptin Biosimilar market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Hereceptin Biosimilar Market Share Analysis
1.1 Hereceptin Biosimilar Product Introduction
1.2 Market Segments
1.3 Key Hereceptin Biosimilar Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hereceptin Biosimilar Market Size Growth Rate by Type
1.4.2 Tablet
1.4.3 Capsule
1.5 Market by Application
1.5.1 Global Hereceptin Biosimilar Market Size Growth Rate by Application
1.5.2 Pharmaceuticals
1.5.3 Healthcare
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hereceptin Biosimilar Market Size, Estimates and Forecasts
2.1.1 Global Hereceptin Biosimilar Revenue 2015-2026
2.1.2 Global Hereceptin Biosimilar Sales 2015-2026
2.2 Global Hereceptin Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hereceptin Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hereceptin Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hereceptin Biosimilar Competitor Landscape by Players
3.1 Hereceptin Biosimilar Sales by Manufacturers
3.1.1 Hereceptin Biosimilar Sales by Manufacturers (2015-2020)
3.1.2 Hereceptin Biosimilar Sales Market Share by Manufacturers (2015-2020)
3.2 Hereceptin Biosimilar Revenue by Manufacturers
3.2.1 Hereceptin Biosimilar Revenue by Manufacturers (2015-2020)
3.2.2 Hereceptin Biosimilar Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hereceptin Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hereceptin Biosimilar Revenue in 2019
3.2.5 Global Hereceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hereceptin Biosimilar Price by Manufacturers
3.4 Hereceptin Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Hereceptin Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hereceptin Biosimilar Product Type
3.4.3 Date of International Manufacturers Enter into Hereceptin Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hereceptin Biosimilar Market Size by Type (2015-2020)
4.1.1 Global Hereceptin Biosimilar Sales by Type (2015-2020)
4.1.2 Global Hereceptin Biosimilar Revenue by Type (2015-2020)
4.1.3 Hereceptin Biosimilar Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hereceptin Biosimilar Market Size Forecast by Type (2021-2026)
4.2.1 Global Hereceptin Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Hereceptin Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Hereceptin Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hereceptin Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hereceptin Biosimilar Market Size by Application (2015-2020)
5.1.1 Global Hereceptin Biosimilar Sales by Application (2015-2020)
5.1.2 Global Hereceptin Biosimilar Revenue by Application (2015-2020)
5.1.3 Hereceptin Biosimilar Price by Application (2015-2020)
5.2 Hereceptin Biosimilar Market Size Forecast by Application (2021-2026)
5.2.1 Global Hereceptin Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Hereceptin Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Hereceptin Biosimilar Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hereceptin Biosimilar by Country
6.1.1 North America Hereceptin Biosimilar Sales by Country
6.1.2 North America Hereceptin Biosimilar Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hereceptin Biosimilar Market Facts & Figures by Type
6.3 North America Hereceptin Biosimilar Market Facts & Figures by Application
7 Europe
7.1 Europe Hereceptin Biosimilar by Country
7.1.1 Europe Hereceptin Biosimilar Sales by Country
7.1.2 Europe Hereceptin Biosimilar Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hereceptin Biosimilar Market Facts & Figures by Type
7.3 Europe Hereceptin Biosimilar Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hereceptin Biosimilar by Region
8.1.1 Asia Pacific Hereceptin Biosimilar Sales by Region
8.1.2 Asia Pacific Hereceptin Biosimilar Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hereceptin Biosimilar Market Facts & Figures by Type
8.3 Asia Pacific Hereceptin Biosimilar Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hereceptin Biosimilar by Country
9.1.1 Latin America Hereceptin Biosimilar Sales by Country
9.1.2 Latin America Hereceptin Biosimilar Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hereceptin Biosimilar Market Facts & Figures by Type
9.3 Central & South America Hereceptin Biosimilar Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hereceptin Biosimilar by Country
10.1.1 Middle East and Africa Hereceptin Biosimilar Sales by Country
10.1.2 Middle East and Africa Hereceptin Biosimilar Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hereceptin Biosimilar Market Facts & Figures by Type
10.3 Middle East and Africa Hereceptin Biosimilar Market Facts & Figures by Application
11 Company Profiles
11.1 Mylan N.V.
11.1.1 Mylan N.V. Corporation Information
11.1.2 Mylan N.V. Description and Business Overview
11.1.3 Mylan N.V. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mylan N.V. Hereceptin Biosimilar Products Offered
11.1.5 Mylan N.V. Related Developments
11.2 AryoGen Biopharma
11.2.1 AryoGen Biopharma Corporation Information
11.2.2 AryoGen Biopharma Description and Business Overview
11.2.3 AryoGen Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AryoGen Biopharma Hereceptin Biosimilar Products Offered
11.2.5 AryoGen Biopharma Related Developments
11.3 Genor Biopharma
11.3.1 Genor Biopharma Corporation Information
11.3.2 Genor Biopharma Description and Business Overview
11.3.3 Genor Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Genor Biopharma Hereceptin Biosimilar Products Offered
11.3.5 Genor Biopharma Related Developments
11.4 Celltrion Inc.
11.4.1 Celltrion Inc. Corporation Information
11.4.2 Celltrion Inc. Description and Business Overview
11.4.3 Celltrion Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celltrion Inc. Hereceptin Biosimilar Products Offered
11.4.5 Celltrion Inc. Related Developments
11.5 Amgen Inc.
11.5.1 Amgen Inc. Corporation Information
11.5.2 Amgen Inc. Description and Business Overview
11.5.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Inc. Hereceptin Biosimilar Products Offered
11.5.5 Amgen Inc. Related Developments
11.6 Mabion S.A.
11.6.1 Mabion S.A. Corporation Information
11.6.2 Mabion S.A. Description and Business Overview
11.6.3 Mabion S.A. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Mabion S.A. Hereceptin Biosimilar Products Offered
11.6.5 Mabion S.A. Related Developments
11.7 The Instituto Vital Brazil
11.7.1 The Instituto Vital Brazil Corporation Information
11.7.2 The Instituto Vital Brazil Description and Business Overview
11.7.3 The Instituto Vital Brazil Sales, Revenue and Gross Margin (2015-2020)
11.7.4 The Instituto Vital Brazil Hereceptin Biosimilar Products Offered
11.7.5 The Instituto Vital Brazil Related Developments
11.8 F. Hoffmann-La Roche AG
11.8.1 F. Hoffmann-La Roche AG Corporation Information
11.8.2 F. Hoffmann-La Roche AG Description and Business Overview
11.8.3 F. Hoffmann-La Roche AG Sales, Revenue and Gross Margin (2015-2020)
11.8.4 F. Hoffmann-La Roche AG Hereceptin Biosimilar Products Offered
11.8.5 F. Hoffmann-La Roche AG Related Developments
11.9 Biocon
11.9.1 Biocon Corporation Information
11.9.2 Biocon Description and Business Overview
11.9.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biocon Hereceptin Biosimilar Products Offered
11.9.5 Biocon Related Developments
11.10 Gedeon Richter Plc
11.10.1 Gedeon Richter Plc Corporation Information
11.10.2 Gedeon Richter Plc Description and Business Overview
11.10.3 Gedeon Richter Plc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Gedeon Richter Plc Hereceptin Biosimilar Products Offered
11.10.5 Gedeon Richter Plc Related Developments
11.1 Mylan N.V.
11.1.1 Mylan N.V. Corporation Information
11.1.2 Mylan N.V. Description and Business Overview
11.1.3 Mylan N.V. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mylan N.V. Hereceptin Biosimilar Products Offered
11.1.5 Mylan N.V. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hereceptin Biosimilar Market Estimates and Projections by Region
12.1.1 Global Hereceptin Biosimilar Sales Forecast by Regions 2021-2026
12.1.2 Global Hereceptin Biosimilar Revenue Forecast by Regions 2021-2026
12.2 North America Hereceptin Biosimilar Market Size Forecast (2021-2026)
12.2.1 North America: Hereceptin Biosimilar Sales Forecast (2021-2026)
12.2.2 North America: Hereceptin Biosimilar Revenue Forecast (2021-2026)
12.2.3 North America: Hereceptin Biosimilar Market Size Forecast by Country (2021-2026)
12.3 Europe Hereceptin Biosimilar Market Size Forecast (2021-2026)
12.3.1 Europe: Hereceptin Biosimilar Sales Forecast (2021-2026)
12.3.2 Europe: Hereceptin Biosimilar Revenue Forecast (2021-2026)
12.3.3 Europe: Hereceptin Biosimilar Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hereceptin Biosimilar Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hereceptin Biosimilar Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hereceptin Biosimilar Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hereceptin Biosimilar Market Size Forecast by Region (2021-2026)
12.5 Latin America Hereceptin Biosimilar Market Size Forecast (2021-2026)
12.5.1 Latin America: Hereceptin Biosimilar Sales Forecast (2021-2026)
12.5.2 Latin America: Hereceptin Biosimilar Revenue Forecast (2021-2026)
12.5.3 Latin America: Hereceptin Biosimilar Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hereceptin Biosimilar Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hereceptin Biosimilar Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hereceptin Biosimilar Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hereceptin Biosimilar Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Hereceptin Biosimilar Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hereceptin Biosimilar Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hereceptin Biosimilar Market Segments
Table 2. Ranking of Global Top Hereceptin Biosimilar Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hereceptin Biosimilar Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Tablet
Table 5. Major Manufacturers of Capsule
Table 6. Global Hereceptin Biosimilar Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Hereceptin Biosimilar Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Hereceptin Biosimilar Sales by Regions 2015-2020 (MT)
Table 9. Global Hereceptin Biosimilar Sales Market Share by Regions (2015-2020)
Table 10. Global Hereceptin Biosimilar Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Hereceptin Biosimilar Sales by Manufacturers (2015-2020) (MT)
Table 12. Global Hereceptin Biosimilar Sales Share by Manufacturers (2015-2020)
Table 13. Global Hereceptin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Hereceptin Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereceptin Biosimilar as of 2019)
Table 15. Hereceptin Biosimilar Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Hereceptin Biosimilar Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Hereceptin Biosimilar Price (2015-2020) (K USD/Kg)
Table 18. Hereceptin Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Hereceptin Biosimilar Product Type
Table 20. Date of International Manufacturers Enter into Hereceptin Biosimilar Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Hereceptin Biosimilar Sales by Type (2015-2020) (MT)
Table 23. Global Hereceptin Biosimilar Sales Share by Type (2015-2020)
Table 24. Global Hereceptin Biosimilar Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Hereceptin Biosimilar Revenue Share by Type (2015-2020)
Table 26. Hereceptin Biosimilar Average Selling Price (ASP) by Type 2015-2020 (K USD/Kg)
Table 27. Global Hereceptin Biosimilar Sales by Application (2015-2020) (MT)
Table 28. Global Hereceptin Biosimilar Sales Share by Application (2015-2020)
Table 29. North America Hereceptin Biosimilar Sales by Country (2015-2020) (MT)
Table 30. North America Hereceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 31. North America Hereceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Hereceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 33. North America Hereceptin Biosimilar Sales by Type (2015-2020) (MT)
Table 34. North America Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 35. North America Hereceptin Biosimilar Sales by Application (2015-2020) (MT)
Table 36. North America Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 37. Europe Hereceptin Biosimilar Sales by Country (2015-2020) (MT)
Table 38. Europe Hereceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 39. Europe Hereceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Hereceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 41. Europe Hereceptin Biosimilar Sales by Type (2015-2020) (MT)
Table 42. Europe Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 43. Europe Hereceptin Biosimilar Sales by Application (2015-2020) (MT)
Table 44. Europe Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Hereceptin Biosimilar Sales by Region (2015-2020) (MT)
Table 46. Asia Pacific Hereceptin Biosimilar Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Hereceptin Biosimilar Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Hereceptin Biosimilar Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Hereceptin Biosimilar Sales by Type (2015-2020) (MT)
Table 50. Asia Pacific Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Hereceptin Biosimilar Sales by Application (2015-2020) (MT)
Table 52. Asia Pacific Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 53. Latin America Hereceptin Biosimilar Sales by Country (2015-2020) (MT)
Table 54. Latin America Hereceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Hereceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Hereceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 57. Latin America Hereceptin Biosimilar Sales by Type (2015-2020) (MT)
Table 58. Latin America Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 59. Latin America Hereceptin Biosimilar Sales by Application (2015-2020) (MT)
Table 60. Latin America Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Hereceptin Biosimilar Sales by Country (2015-2020) (MT)
Table 62. Middle East and Africa Hereceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Hereceptin Biosimilar Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Hereceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Hereceptin Biosimilar Sales by Type (2015-2020) (MT)
Table 66. Middle East and Africa Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Hereceptin Biosimilar Sales by Application (2015-2020) (MT)
Table 68. Middle East and Africa Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Table 69. Mylan N.V. Corporation Information
Table 70. Mylan N.V. Description and Major Businesses
Table 71. Mylan N.V. Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 72. Mylan N.V. Product
Table 73. Mylan N.V. Recent Development
Table 74. AryoGen Biopharma Corporation Information
Table 75. AryoGen Biopharma Description and Major Businesses
Table 76. AryoGen Biopharma Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 77. AryoGen Biopharma Product
Table 78. AryoGen Biopharma Recent Development
Table 79. Genor Biopharma Corporation Information
Table 80. Genor Biopharma Description and Major Businesses
Table 81. Genor Biopharma Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 82. Genor Biopharma Product
Table 83. Genor Biopharma Recent Development
Table 84. Celltrion Inc. Corporation Information
Table 85. Celltrion Inc. Description and Major Businesses
Table 86. Celltrion Inc. Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 87. Celltrion Inc. Product
Table 88. Celltrion Inc. Recent Development
Table 89. Amgen Inc. Corporation Information
Table 90. Amgen Inc. Description and Major Businesses
Table 91. Amgen Inc. Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 92. Amgen Inc. Product
Table 93. Amgen Inc. Recent Development
Table 94. Mabion S.A. Corporation Information
Table 95. Mabion S.A. Description and Major Businesses
Table 96. Mabion S.A. Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 97. Mabion S.A. Product
Table 98. Mabion S.A. Recent Development
Table 99. The Instituto Vital Brazil Corporation Information
Table 100. The Instituto Vital Brazil Description and Major Businesses
Table 101. The Instituto Vital Brazil Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 102. The Instituto Vital Brazil Product
Table 103. The Instituto Vital Brazil Recent Development
Table 104. F. Hoffmann-La Roche AG Corporation Information
Table 105. F. Hoffmann-La Roche AG Description and Major Businesses
Table 106. F. Hoffmann-La Roche AG Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 107. F. Hoffmann-La Roche AG Product
Table 108. F. Hoffmann-La Roche AG Recent Development
Table 109. Biocon Corporation Information
Table 110. Biocon Description and Major Businesses
Table 111. Biocon Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 112. Biocon Product
Table 113. Biocon Recent Development
Table 114. Gedeon Richter Plc Corporation Information
Table 115. Gedeon Richter Plc Description and Major Businesses
Table 116. Gedeon Richter Plc Hereceptin Biosimilar Production (MT), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 117. Gedeon Richter Plc Product
Table 118. Gedeon Richter Plc Recent Development
Table 119. Global Hereceptin Biosimilar Sales Forecast by Regions (2021-2026) (MT)
Table 120. Global Hereceptin Biosimilar Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Hereceptin Biosimilar Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Hereceptin Biosimilar Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Hereceptin Biosimilar Sales Forecast by Country (2021-2026) (MT)
Table 124. North America: Hereceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Hereceptin Biosimilar Sales Forecast by Country (2021-2026) (MT)
Table 126. Europe: Hereceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Hereceptin Biosimilar Sales Forecast by Region (2021-2026) (MT)
Table 128. Asia Pacific: Hereceptin Biosimilar Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Hereceptin Biosimilar Sales Forecast by Country (2021-2026) (MT)
Table 130. Latin America: Hereceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Hereceptin Biosimilar Sales Forecast by Country (2021-2026) (MT)
Table 132. Middle East and Africa: Hereceptin Biosimilar Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Hereceptin Biosimilar Players
Table 137. Hereceptin Biosimilar Customers List
Table 138. Hereceptin Biosimilar Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Hereceptin Biosimilar Product Picture
Figure 2. Global Hereceptin Biosimilar Sales Market Share by Type in 2020 & 2026
Figure 3. Tablet Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Hereceptin Biosimilar Sales Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals
Figure 7. Healthcare
Figure 8. Others
Figure 9. Hereceptin Biosimilar Report Years Considered
Figure 10. Global Hereceptin Biosimilar Market Size 2015-2026 (US$ Million)
Figure 11. Global Hereceptin Biosimilar Sales 2015-2026 (MT)
Figure 12. Global Hereceptin Biosimilar Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Hereceptin Biosimilar Sales Market Share by Region (2015-2020)
Figure 14. Global Hereceptin Biosimilar Sales Market Share by Region in 2019
Figure 15. Global Hereceptin Biosimilar Revenue Market Share by Region (2015-2020)
Figure 16. Global Hereceptin Biosimilar Revenue Market Share by Region in 2019
Figure 17. Global Hereceptin Biosimilar Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Hereceptin Biosimilar Revenue in 2019
Figure 19. Hereceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
Figure 21. Global Hereceptin Biosimilar Sales Market Share by Type in 2019
Figure 22. Global Hereceptin Biosimilar Revenue Market Share by Type (2015-2020)
Figure 23. Global Hereceptin Biosimilar Revenue Market Share by Type in 2019
Figure 24. Global Hereceptin Biosimilar Market Share by Price Range (2015-2020)
Figure 25. Global Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
Figure 26. Global Hereceptin Biosimilar Sales Market Share by Application in 2019
Figure 27. Global Hereceptin Biosimilar Revenue Market Share by Application (2015-2020)
Figure 28. Global Hereceptin Biosimilar Revenue Market Share by Application in 2019
Figure 29. North America Hereceptin Biosimilar Sales Growth Rate 2015-2020 (MT)
Figure 30. North America Hereceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Hereceptin Biosimilar Sales Market Share by Country in 2019
Figure 32. North America Hereceptin Biosimilar Revenue Market Share by Country in 2019
Figure 33. U.S. Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 34. U.S. Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 36. Canada Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Hereceptin Biosimilar Market Share by Type in 2019
Figure 38. North America Hereceptin Biosimilar Market Share by Application in 2019
Figure 39. Europe Hereceptin Biosimilar Sales Growth Rate 2015-2020 (MT)
Figure 40. Europe Hereceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Hereceptin Biosimilar Sales Market Share by Country in 2019
Figure 42. Europe Hereceptin Biosimilar Revenue Market Share by Country in 2019
Figure 43. Germany Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 44. Germany Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 46. France Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 48. U.K. Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 50. Italy Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 52. Russia Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Hereceptin Biosimilar Market Share by Type in 2019
Figure 54. Europe Hereceptin Biosimilar Market Share by Application in 2019
Figure 55. Asia Pacific Hereceptin Biosimilar Sales Growth Rate 2015-2020 (MT)
Figure 56. Asia Pacific Hereceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Hereceptin Biosimilar Sales Market Share by Region in 2019
Figure 58. Asia Pacific Hereceptin Biosimilar Revenue Market Share by Region in 2019
Figure 59. China Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 60. China Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 62. Japan Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 64. South Korea Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 66. India Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 68. Australia Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 70. Taiwan Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 72. Indonesia Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 74. Thailand Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 76. Malaysia Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 78. Philippines Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 80. Vietnam Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Hereceptin Biosimilar Market Share by Type in 2019
Figure 82. Asia Pacific Hereceptin Biosimilar Market Share by Application in 2019
Figure 83. Latin America Hereceptin Biosimilar Sales Growth Rate 2015-2020 (MT)
Figure 84. Latin America Hereceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Hereceptin Biosimilar Sales Market Share by Country in 2019
Figure 86. Latin America Hereceptin Biosimilar Revenue Market Share by Country in 2019
Figure 87. Mexico Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 88. Mexico Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 90. Brazil Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 92. Argentina Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Hereceptin Biosimilar Market Share by Type in 2019
Figure 94. Latin America Hereceptin Biosimilar Market Share by Application in 2019
Figure 95. Middle East and Africa Hereceptin Biosimilar Sales Growth Rate 2015-2020 (MT)
Figure 96. Middle East and Africa Hereceptin Biosimilar Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Hereceptin Biosimilar Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Hereceptin Biosimilar Revenue Market Share by Country in 2019
Figure 99. Turkey Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 100. Turkey Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 102. Saudi Arabia Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Hereceptin Biosimilar Sales Growth Rate (2015-2020) (MT)
Figure 104. U.A.E Hereceptin Biosimilar Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Hereceptin Biosimilar Market Share by Type in 2019
Figure 106. Middle East and Africa Hereceptin Biosimilar Market Share by Application in 2019
Figure 107. North America Hereceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (MT)
Figure 108. North America Hereceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Hereceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (MT)
Figure 110. Europe Hereceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Hereceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (MT)
Figure 112. Asia Pacific Hereceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Hereceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (MT)
Figure 114. Latin America Hereceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Hereceptin Biosimilar Sales Growth Rate Forecast (2021-2026) (MT)
Figure 116. Middle East and Africa Hereceptin Biosimilar Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
